comparemela.com

Latest Breaking News On - Capital cs group - Page 14 : comparemela.com

KWB Wealth Buys 12,556 Shares of SPDR Portfolio Developed World ex-US ETF (NYSEARCA:SPDW)

KWB Wealth lifted its stake in SPDR Portfolio Developed World ex-US ETF (NYSEARCA:SPDW – Get Rating) by 1.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,032,970 shares of the company’s stock after acquiring an additional 12,556 shares during the […]

Front Street Capital Management Inc Lowers Stake in Rollins, Inc (NYSE:ROL)

Alyeska Investment Group L.P. reduced its stake in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 7.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 663,830 shares of the medical device company’s stock after selling 51,087 shares during the quarter. Alyeska […]

Equillium, Inc (NASDAQ:EQ) Shares Acquired by True North Advisors LLC

True North Advisors LLC lifted its position in shares of Equillium, Inc. (NASDAQ:EQ – Get Rating) by 50.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 265,370 shares of the company’s stock after purchasing an additional 89,060 shares during the period. True North Advisors LLC’s holdings in Equillium were worth $265,000 at the […]

First Trust Advisors LP Makes New Investment in Immunocore Holdings plc (NASDAQ:IMCR)

First Trust Advisors LP bought a new position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 13,975 shares of the company’s stock, valued at approximately $798,000. Other hedge funds also recently added to […]

Mirova Sells 1,066 Shares of DexCom, Inc (NASDAQ:DXCM)

Mirova decreased its position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 36.1% during the 4th quarter, Holdings Channel reports. The firm owned 1,886 shares of the medical device company’s stock after selling 1,066 shares during the period. Mirova’s holdings in DexCom were worth $214,000 at the end of the most recent quarter. Other institutional […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.